CONTROVERSIAL ISSUES IN THE TREATMENT OF PATIENTS WITH T3N0–2M0 LARYNGEAL FOLD CANCER

Cover Page

Cite item

Full Text

Abstract

The paper gives the results of surgical, combined, and chemoradiation treatments in 102 patients with laryngeal fold cancer of the extent corresponding to T3N0–2M0, who have been treated at the Department for Surgery of Upper Respiratory and Digestive Tracts, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences. It discusses the influence of different prognostic factors on survival, as well as recommendations to determine the most optimal treatment policy in this category of patients.

About the authors

A. Sh. Taneeva

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Author for correspondence.
Email: alityaliya@mail.ru
Russian Federation

A. M. Mudunov

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: alityaliya@mail.ru
Russian Federation

S. B. Alieva

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: alityaliya@mail.ru
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 36990 от  21.07.2009.